Bright Green Corp financial data

Symbol
BGXX on Nasdaq
Industry
Medicinal Chemicals & Botanical Products
Location
401 East Las Olas Blvd., Suite 1400, Ft. Lauderdale, FL
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.86 % -86.6%
Debt-to-equity 54.9 % -31.7%
Return On Equity -83.4 % +22.3%
Return On Assets -53.8 % +9.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 191M shares +6.43%
Common Stock, Shares, Outstanding 190M shares +5.95%
Entity Public Float 75.1M USD -47.1%
Common Stock, Value, Issued 19K USD +5.96%
Weighted Average Number of Shares Outstanding, Basic 190M shares +7.9%
Weighted Average Number of Shares Outstanding, Diluted 190M shares +7.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
General and Administrative Expense 6.08M USD -50.8%
Operating Income (Loss) -6.69M USD +48.5%
Nonoperating Income (Expense) 80.1K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.7M USD +26.6%
Net Income (Loss) Attributable to Parent -9.92M USD +25.8%
Earnings Per Share, Basic -0.05 USD/shares +44.4%
Earnings Per Share, Diluted -0.05 USD/shares +50%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 135K USD -80.4%
Property, Plant and Equipment, Net 15.8M USD -17.1%
Intangible Assets, Net (Excluding Goodwill) 9.01K USD +801%
Assets 16M USD -35.8%
Accounts Payable, Current 4.77M USD -11.8%
Accrued Liabilities, Current 37.2K USD -96.1%
Liabilities, Current 6.12M USD -23.6%
Liabilities 6.12M USD -47.1%
Retained Earnings (Accumulated Deficit) -49.6M USD -25%
Stockholders' Equity Attributable to Parent 9.86M USD -26%
Liabilities and Equity 16M USD -35.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -58.6K USD -121%
Net Cash Provided by (Used in) Financing Activities 110K USD -91.4%
Net Cash Provided by (Used in) Investing Activities -61.5K USD +96%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 190M shares +5.95%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.1K USD -227%
Deferred Tax Assets, Valuation Allowance 11.1M USD +38.6%
Deferred Tax Assets, Gross 11.1M USD +38.6%
Depreciation 610K USD -3.96%
Payments to Acquire Property, Plant, and Equipment 56.1K USD -96.5%
Property, Plant and Equipment, Gross 19.6M USD -11.9%
Deferred Tax Assets, Operating Loss Carryforwards 9.72M USD +33.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense 15K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%